Monday, Sept 9th (Presidential Symposium Press Briefing)

Moderator: Giorgio Scagliotti/Webcasts at bottom of page

• Summary of day’s plenary (5 mins) and any key highlights/themes
• Lung Cancer Screen Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Finding -- S. Lam
• Early Detection of Cancer of the Lung Scotland (ECLS): Trial Results -- F. Sullivan
• Blood MicroRNA and LDCT Reduce Unnecessary LDCT Repeats in Lung Cancer Screening: Results of Prospective BioMILD -- U. Pastorino
• In Hospital Clinical Efficacy, Safety and Oncologic Outcomes from VIOLET: A UK Multi-Centre RCT of VATS Versus Open Lobectomy for Lung Cancer -- E. Lim
• Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers -- A. Drilon
• National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC) -- G. Middleton
• Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study -- L. Paz-Ares